FindMyKOL
Clinical trialNCT06690801RecruitingObservational

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

SponsorChildren's Hospital Los AngelesEnrollment1,260Acute Respiratory Distress Syndrome
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this observational study is to determine whether a marker of dead space (the end-tidal to alveolar dead space fraction \[AVDSf\]) is more strongly associated with mortality risk than markers of oxygenation abnormality (oxygenation index) and to determine whether dead space (AVDSf) is an important marker of heterogeneity in the inhaled nitric oxide (iNO) treatment effect for children with acute respiratory distress syndrome (ARDS). The study aims are: 1. To validate AVDSf for risk stratification of mortality in pediatric ARDS 2. To determine if there is heterogeneity in treatment effect for iNO defined by AVDSf 3. To detect the association between AVDSf and microvascular dysfunction trajectory and whether iNO therapy modifies this association This is a prospective, multicenter observational study of 1260 mechanically ventilated children with moderate to severe ARDS. In a subgroup of 450 children with severe ARDS, longitudinal blood samples will be obtained to measure plasma protein markers.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Children'S Hospital Los Angeles

    Los Angeles, California, United States

    Anoopindar Bhalla, MD
    Recruiting
  • Children'S Hospital Colorado

    Denver, Colorado, United States

    Aline Maddux, MD
    Not, yet, recruiting
  • Boston Children'S Hospital

    Boston, Massachusetts, United States

    Sally Vitali, MD
    Not, yet, recruiting
  • University of Michigan / Cs Mott Children'S Hospital

    Ann Arbor, Michigan, United States

    Active, not recruiting
  • University of Nebraska Medical Center / Children'S Hospital and Medical Center

    Omaha, Nebraska, United States

    Eleanor Gradidge, MD
    Not, yet, recruiting
  • Cincinnati Children'S Hospital Medical Center

    Cincinnati, Ohio, United States

    Steve Standage, MD
    Not, yet, recruiting
  • Children'S Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States

    Adam Himebauch, MD
    Not, yet, recruiting
  • Texas Children'S Hospital Baylor College of Medicine

    Houston, Texas, United States

    Manpreet Virk, MD
    Not, yet, recruiting
  • American Family Children'S Hospital / University of Wisconsin-Madison

    Madison, Wisconsin, United States

    Awni Al-Subu, MD
    Not, yet, recruiting
  • Children'S Hospital of Wisconsin / Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

    Jasmine Dowell, MD
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 Oct 2024
Primary completion
1 Dec 2028
Completion
1 Feb 2029
Last update posted
15 Nov 2024
Registered enrollment
1,260
Registry id
NCT06690801

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.